• 2003

Company Description

Tau Therapeutics engages in the R&D, repositioning and commercialization of calcium T-channel therapies for oncology and other diseases.

Tau Therapeutics LLC, a development stage biopharmaceutical company, focuses on the research, development, repositioning, and commercialization of calcium T-channel therapy agents as cytostatic anti-cancer drugs. It offers calcium T-channel blockers for oncology and other diseases. The company was founded in 2003 and is based in Charlottesville, Virginia.